Search

Insulet Corp

Closed

SectorHealthcare

147.3 -2.04

Overview

Share price change

24h

Current

Min

146.52

Max

147.91

Key metrics

By Trading Economics

Income

3.9M

95M

Sales

40M

802M

P/E

Sector Avg

27.227

56.659

EPS

1.66

Profit margin

11.85

Employees

5,400

EBITDA

-22M

132M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+16.25% upside

Dividends

By Acuity

Next Earnings

5 lis 2026

Market Stats

By TradingEconomics

Market Cap

-1.4B

10B

Previous open

149.34

Previous close

147.3

News Sentiment

By Acuity

67%

33%

292 / 339 Ranking in Healthcare

Insulet Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 wrz 2026, 20:07 UTC

Insulet Corp's shares are lower today, reaching a session low earlier. The stock remains above its 20-day moving average amid notable volatility.

3 wrz 2026, 22:46 UTC

Insulet Corp shares are lower in after-market hours, despite earlier gains. No specific news was identified to explain the price movement.

2 wrz 2026, 19:36 UTC

Insulet Corp shares are declining today, despite an earlier peak. Broader market concerns include heightened geopolitical tensions and potential supply disruptions.

1 wrz 2026, 23:36 UTC

Insulet Corp's shares are higher in after-market hours, following notable trading activity. The stock remains above its 20-day moving average despite negative market sentiment.

31 sie 2026, 20:07 UTC

News

Insulet Corp reported 23.5% revenue growth for Q2 2026, though it lowered FY2026 guidance. Shares are gaining today amid broader market trends.

28 sie 2026, 19:16 UTC

Insulet Corp's shares are higher today, reflecting positive market sentiment despite earlier intraday volatility. No specific news was identified to explain the movement.

27 sie 2026, 19:26 UTC

News

Insulet Corp faces a class action lawsuit alleging securities fraud related to manufacturing defects, contributing to a decline in shares today.

26 sie 2026, 19:16 UTC

Social Media

Insulet Corp shares are higher today, supported by over $226,000 in December $200 call options. Recent PCE data may also influence market sentiment.

25 sie 2026, 23:16 UTC

News

Insulet Corp shares lower in after-market hours amid a class action lawsuit alleging false statements about manufacturing controls and safety compliance.

24 sie 2026, 19:56 UTC

News

Insulet Corp shares are lower amid negative sentiment from two class action lawsuits alleging securities fraud related to product safety concerns.

21 sie 2026, 19:56 UTC

Insulet Corp shares are higher today, reflecting positive market momentum. Broader market gains, particularly in cryptocurrency, contribute to the stock's upward movement.

20 sie 2026, 23:11 UTC

Insulet Corp shares are trading lower in after-market hours, continuing a decline that follows a reversal from earlier highs. No specific news was identified.

19 sie 2026, 23:01 UTC

Insulet Corp shares are higher in after-market trading, continuing a trend of gains over the last three sessions without any specific news driving the movement.

18 sie 2026, 20:03 UTC

Insulet Corp's shares are higher today, having previously peaked before pulling back. The stock has advanced since Monday's close, despite no specific news.

17 sie 2026, 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

14 sie 2026, 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

13 sie 2026, 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

12 sie 2026, 19:36 UTC

Insulet Corp shares are higher during Wednesday's session, recovering from earlier lows. Broader market inflation data may be supporting positive sentiment.

11 sie 2026, 19:46 UTC

Insulet Corp's shares are higher, continuing a four-session trend, despite no specific news. Market participants are reacting to recent economic indicators and Fed rate expectations.

10 sie 2026, 22:56 UTC

News

Insulet Corp shares are lower in after-market trading following a class action lawsuit from Pomerantz LLP alleging false statements about manufacturing practices and product safety.

7 sie 2026, 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

6 sie 2026, 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

5 sie 2026, 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4 sie 2026, 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3 sie 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 lip 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 lip 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28 lip 2026, 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27 lip 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 lip 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

Peer Comparison

Price change

Insulet Corp Forecast

Price Target

By TipRanks

16.25% upside

12 Months Forecast

Average 171.44 USD  16.25%

High 216 USD

Low 144 USD

Based on 21 Wall Street analysts offering 12 month price targets forInsulet Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

21 ratings

12

Buy

9

Hold

0

Sell

Sentiment

By Acuity

292 / 339 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat